← Leaderboards
Italo Mocchetti
Georgetown University
$14,386,207
Attributed
$15,094,698
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,094,698 · 15
By mechanism
R01$10,476,222 · 3
R21$3,785,837 · 10
T32$755,358 · 1
P30$77,281 · 1
Top collaborators
- Marta L. Catalfamo5 shared
- Valeria Avdoshina2 shared
- Lee Campbell1 shared
Others in their field
Top investigators on “Hiv Envelope Protein Gp120”
- Barton F Haynes · Duke University$106,842,828
- David Heimbrook · Leidos Biomedical Research, Inc.$42,703,445
- Joseph G Sodroski · University Of Pennsylvania$33,768,964
- Richard Thomas Wyatt · Scripps Research Institute, The$19,541,170
- Kurt Francis Hauser · University Of Kentucky$19,114,808
- Cynthia Ann Derdeyn · Emory University$18,753,159
Research focus
Hiv Envelope Protein Gp120NeuronsBrainMediatingExhibitsNeurotoxicHiv-1NeurotoxicityMolecularCellsImpaired CognitionRattusEnv Gene ProductsSynapsesViral ProteinsNeuron LossAffectIn VitroNerve DegenerationBrain-Derived Neurotrophic FactorLeadPreventReceptorAids Dementia Complex
Grant awards (49)
Role of proBNDF and p75NTR in HIV-mediated Axonal/Dendritic Degeneration$623,359
R01 · FY2025 · NS · contact PI
Probing the effect of opioids on HIV transcription and latency using a novel dual fluorescent and bioluminescent virus$234,000
R21 · FY2025 · DA · contact PI
Training Program in NeuroHIV (TPNH)$174,800
T32 · FY2025 · NS · contact PI
Aging and Comorbidities SWG$77,281
P30 · FY2025 · AI · contact PI
Role of proBNDF and p75NTR in HIV-mediated Axonal/Dendritic Degeneration$623,359
R01 · FY2024 · NS · contact PI
Training Program in NeuroHIV (TPNH)$153,921
T32 · FY2024 · NS · contact PI
Role of proBNDF and p75NTR in HIV-mediated Axonal/Dendritic Degeneration$546,020
R01 · FY2023 · NS · contact PI
Training Program in NeuroHIV (TPNH)$173,834
T32 · FY2023 · NS · contact PI
Role of proBNDF and p75NTR in HIV-mediated Axonal/Dendritic Degeneration$516,729
R01 · FY2022 · NS · contact PI
HIV promotes dendritic degeneration by altering microtubule-associated protein$429,000
R21 · FY2022 · NS · contact PI
Training Program in NeuroHIV (TPNH)$169,769
T32 · FY2022 · NS · contact PI
Role of proBNDF and p75NTR in HIV-mediated Axonal/Dendritic Degeneration$546,020
R01 · FY2021 · NS · contact PI
Training Program in NeuroHIV (TPNH)$83,034
T32 · FY2021 · NS · contact PI
Role of proBNDF and p75NTR in HIV-mediated Axonal/Dendritic Degeneration$546,020
R01 · FY2020 · NS · contact PI
Role of proBNDF and p75NTR in HIV-mediated Axonal/Dendritic Degeneration$546,276
R01 · FY2019 · NS · contact PI
Gp120 binds to neuronal microtubules: a new mechanism for synaptic simplification$194,375
R21 · FY2018 · NS · contact PI
Opioid withdrawal and microglia: synergistic effect with HIV-mediated neurodegeneration?$194,375
R21 · FY2018 · NS · contact PI
Gp120 binds to neuronal microtubules: a new mechanism for synaptic simplification$233,250
R21 · FY2017 · NS · contact PI
Opioid withdrawal and microglia: synergistic effect with HIV-mediated neurodegeneration?$233,250
R21 · FY2017 · NS · contact PI
Role of proBDNF and p75NTR in HIV-mediated axonal/dendritic degeneration$494,241
R01 · FY2016 · NS · contact PI
Role of proBDNF and p75NTR in HIV-mediated axonal/dendritic degeneration$494,241
R01 · FY2015 · NS · contact PI
GPR75: a new CCL5 receptor that mediates neuroprotection against HIV$233,250
R21 · FY2015 · NS · contact PI
Role of proBDNF and p75NTR in HIV-mediated axonal/dendritic degeneration$489,299
R01 · FY2014 · NS · contact PI
GPR75: a new CCL5 receptor that mediates neuroprotection against HIV$194,375
R21 · FY2014 · NS · contact PI
Role of proBDNF and p75NTR in HIV-mediated axonal/dendritic degeneration$479,321
R01 · FY2013 · NS · contact PI
Role of proBDNF and p75NTR in HIV-mediated axonal/dendritic degeneration$485,235
R01 · FY2012 · NS · contact PI
HIV drug abusers, polymorphisms and brain plasticity$356,633
R01 · FY2012 · DA · contact PI
Cellular and molecular mechanisms of gp120 neurotoxicity$193,854
R21 · FY2012 · NS · contact PI
HIV drug abusers, polymorphisms and brain plasticity$356,846
R01 · FY2011 · DA · contact PI
Cellular and molecular mechanisms of gp120 neurotoxicity$232,500
R21 · FY2011 · NS · contact PI
HIV drug abusers, polymorphisms and brain plasticity$357,170
R01 · FY2010 · DA · contact PI
HIV drug abusers, polymorphisms and brain plasticity$350,267
R01 · FY2009 · DA · contact PI
Neuroprotective agents in HIV-1 associated dementia$167,891
R21 · FY2009 · NS · contact PI
HIV drug abusers, polymorphisms and brain plasticity$354,816
R01 · FY2008 · DA · contact PI
Neurotrophic factors and HIV-mediated neuronal injury$340,302
R01 · FY2008 · NS · contact PI
Neuroprotective agents in HIV-1 associated dementia$201,469
R21 · FY2008 · NS · contact PI
Neurotrophic factors and HIV-mediated neuronal injury$340,302
R01 · FY2007 · NS · contact PI
Neuronal Apoptosis Induced by DNA Damage$169,537
R21 · FY2007 · NS · contact PI
Neurotrophic factors and HIV-mediated neuronal injury$77,577
R01 · FY2007 · NS · contact PI
Neurotrophic factors and HIV-mediated neuronal injury$350,466
R01 · FY2006 · NS · contact PI
Neuronal Apoptosis Induced by DNA Damage$209,520
R21 · FY2006 · NS · contact PI
Antidepressants and Fibroblast Growth Factor$151,553
R21 · FY2006 · MH · contact PI
Neurotrophic factors and HIV-mediated neuronal injury$350,709
R01 · FY2005 · NS
Neuronal transport of gp120$179,219
R21 · FY2005 · NS
Antidepressants and Fibroblast Growth Factor$155,200
R21 · FY2005 · MH
Neuronal transport of gp120$179,219
R21 · FY2004 · NS
Neurotrophic factors and HIV mediated neuronal injury$267,543
R01 · FY2003 · NS
Neurotrophic factors and HIV mediated neuronal injury$267,212
R01 · FY2002 · NS
Neurotrophic factors and HIV mediated neuronal injury$316,259
R01 · FY2001 · NS